Your browser doesn't support javascript.
loading
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.
Pardanani, Animesh; Harrison, Claire; Cortes, Jorge E; Cervantes, Francisco; Mesa, Ruben A; Milligan, Donald; Masszi, Tamás; Mishchenko, Elena; Jourdan, Eric; Vannucchi, Alessandro M; Drummond, Mark W; Jurgutis, Mindaugas; Kuliczkowski, Kazimierz; Gheorghita, Emanuil; Passamonti, Francesco; Neumann, Frank; Patki, Abhay; Gao, Guozhi; Tefferi, Ayalew.
Afiliação
  • Pardanani A; Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Harrison C; Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, England.
  • Cortes JE; University of Texas MD Anderson Cancer Center, Houston.
  • Cervantes F; Hospital Clinic, IDIBAPS University of Barcelona, Barcelona, Spain.
  • Mesa RA; Division of Hematology-Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Milligan D; Centre for Haematology and Stem Cell Transplantation, Heartlands Hospital, Birmingham, England.
  • Masszi T; Department of Haematology and Stem Cell Transplantation, St István and St László Hospital, Budapest, Hungary.
  • Mishchenko E; Hematology-Oncology Unit, Bnai-Zion Medical Center, Haifa, Israel.
  • Jourdan E; Groupe Hospitalo-Universitaire Nimes, Nimes, France.
  • Vannucchi AM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Drummond MW; Beatson West of Scotland Cancer Centre, Gartnavel General Hospital, Glasgow, Scotland.
  • Jurgutis M; Hematology Department, Klaipeda Seamen's Hospital, Klaipeda, Lithuania.
  • Kuliczkowski K; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Gheorghita E; Brasov Country Hospital, Brasov, Romania.
  • Passamonti F; University Hospital Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
  • Neumann F; Sanofi Oncology, Cambridge, Massachusetts.
  • Patki A; Sanofi Oncology, Cambridge, Massachusetts.
  • Gao G; Sanofi Oncology, Cambridge, Massachusetts.
  • Tefferi A; Department of Medicine, Mayo Clinic, Rochester, Minnesota.
JAMA Oncol ; 1(5): 643-51, 2015 Aug.
Article em En | MEDLINE | ID: mdl-26181658
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinas / Esplenomegalia / Sulfonamidas / Inibidores de Proteínas Quinases / Mielofibrose Primária / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: JAMA Oncol Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinas / Esplenomegalia / Sulfonamidas / Inibidores de Proteínas Quinases / Mielofibrose Primária / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: JAMA Oncol Ano de publicação: 2015 Tipo de documento: Article